WASHINGTON (Reuters) - Genetic tests designed to predict how well lung cancer patients will fare after treatment do very little to guide doctors, government researchers said on Tuesday. Their review of studies aiming to show a gene signature for lung tumors found serious problems in the design and analysis of the studies. Researchers need some clear guidelines to follow in what ...

CHICAGO (Reuters) - Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer, U.S. researchers said on Tuesday. They said intensive radiation therapy -- done in one to five treatments instead of the conventional 20 to 30 -- provided more than double the rate of primary tumor control ...

Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an independent monitoring committee recommended stopping the study. It concluded that figitumumab in conjunction with Tarceva ...

NEW YORK (Reuters Health) - Women infected with HIV or at risk of becoming infected with HIV, the virus that causes AIDS, appear more likely to develop lung cancer than women in the general population, possibly because they are much more likely to smoke cigarettes, study findings hint. People with HIV have a much higher risk for many cancers. Still, it ...